Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction
Biljana Musicki1, Anthony J Bella2, Trinity J Bivalacqua1
1The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
Insights
Cardiovascular/metabolic diseases (CVMD) are mechanistically linked to erectile dysfunction (ED) through endothelial, smooth muscle, autonomic, hormonal, and metabolic pathways. Further research is recommended to define this relationship and develop new therapies.
Area of Science:
- Basic Science
- Sexual Medicine
- Cardiovascular Research
Background:
- Clinical evidence links cardiovascular/metabolic diseases (CVMD) with erectile dysfunction (ED).
- The underlying scientific mechanisms connecting CVMD and ED require further elucidation.
- Understanding these links is crucial for developing targeted therapeutic interventions.
Purpose of the Study:
- To provide comprehensive scientific evidence for the mechanistic link between CVMD and ED.
- To critically assess current preclinical models for studying the ED-CVMD relationship.
- To identify knowledge gaps and propose future research directions.
Main Methods:
- A White Paper approach was utilized by the Basic Science Committee of the Sexual Medicine Society of North America.
- Literature review focused on basic scientific support for mechanistic links between ED and CVMD.
- Assessment included an evaluation of deficiencies in current preclinical models.
Main Results:
- A link between ED and CVMD is supported by evidence in multiple physiological systems.
- Key areas include endothelial function (nitric oxide, oxidative stress), smooth muscle contractility, and autonomic innervation.
- Hormonal imbalances (testosterone) and metabolic dysfunctions (hyperlipidemia, glycation) also contribute.
Conclusions:
- Basic science robustly supports the association between ED and CVMD.
- Identified knowledge gaps necessitate further scientific investigation.
- Recommendations are provided to guide future research and therapeutic strategy development.
Introduction:
Although clinical evidence supports an association between cardiovascular/metabolic diseases (CVMD) and erectile dysfunction (ED), scientific evidence for this link is incompletely elucidated.
Aim:
This study aims to provide scientific evidence for the link between CVMD and ED.
Methods:
In this White Paper, the Basic Science Committee of the Sexual Medicine Society of North America assessed the current literature on basic scientific support for a mechanistic link between ED and CVMD, and deficiencies in this regard with a critical assessment of current preclinical models of disease.
Results:
A link exists between ED and CVMD on several grounds: the endothelium (endothelium-derived nitric oxide and oxidative stress imbalance); smooth muscle (SM) (SM abundance and altered molecular regulation of SM contractility); autonomic innervation (autonomic neuropathy and decreased neuronal-derived nitric oxide); hormones (impaired testosterone release and actions); and metabolics (hyperlipidemia, advanced glycation end product formation).
Conclusion:
Basic science evidence supports the link between ED and CVMD. The Committee also highlighted gaps in knowledge and provided recommendations for guiding further scientific study defining this risk relationship. This endeavor serves to develop novel strategic directions for therapeutic interventions.
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure I: Introduction
